The cutting-edge weight-loss drug Ozempic/Wegovy can cease and even reverse fatty liver illness, a brand new medical trial has discovered.
Nearly twice as many individuals taking semaglutide stopped their fatty liver illness with out additional scarring of the organ—63%, in contrast with 34% of these taking a placebo, researchers reported April 30 within the New England Journal of Medicine.
An estimated 15 million Americans—1 in 20 adults—endure from fatty liver illness, also called metabolic dysfunction-associated steatohepatitis (MASH), researchers stated in background notes.
Results from the medical trial “present robust proof that semaglutide might help sufferers with MASH by not solely bettering liver well being, but additionally addressing the underlying metabolic points that contribute to the illness,” lead researcher Dr. Arun Sanyal, director of the Virginia Commonwealth University Stravitz-Sanyal Institute for Liver Disease and Metabolic Health, stated in a information launch.
MASH happens when fats builds up within the liver, resulting in irritation and scarring. The {condition} has been linked to weight problems, kind 2 diabetes, elevated levels of cholesterol and hypertension, in accordance with the Cleveland Clinic.
Semaglutide is a glucagon-like peptide-1 (GLP-1) drug. It works by mimicking the GLP-1 hormone, which helps {control} insulin and blood sugar ranges, decreases urge for food and slows digestion of meals.
For the medical trial, researchers recruited 800 folks in 37 nations with average to extreme liver scarring from fatty liver illness and randomly assigned roughly two-thirds to take semaglutide for 72 weeks.
Along with a discount in liver irritation, about 37% of semaglutide customers confirmed much less liver scarring in comparison with about 23% within the placebo group, researchers stated.
Overall, a few third of semaglutide customers achieved each irritation discount and scarring enchancment, greater than double these taking placebo, outcomes present.
Semaglutide additionally helped folks drop a few pounds, enhance their liver perform, and enhance their general coronary heart well being, researchers stated.
“By treating each liver illness and its metabolic causes, semaglutide gives a promising new strategy for tens of millions of sufferers,” Sanyal stated.
Currently, there is just one U.S. government-approved remedy out there for fatty liver illness, Rezdiffra (resmetirom), researchers stated. It works by activating a thyroid hormone receptor that promotes discount of fats buildup within the liver.
The producer of semaglutide, Novo Nordisk, plans to hunt U.S. Food and Drug Administration (FDA) approval for the drug to deal with fatty liver illness later this yr, researchers stated.
More info:
Arun J. Sanyal et al, Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis, New England Journal of Medicine (2025). DOI: 10.1056/NEJMoa2413258
The Cleveland Clinic has extra on fatty liver disease.
Citation:
Ozempic can deal with fatty liver illness ( 1)
3
ozempic-fatty-liver-disease.html
.
. The content material is supplied for info functions solely.